{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:16:09Z","timestamp":1776446169446,"version":"3.51.2"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1054\/mehy.2001.1333","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:42Z","timestamp":1032447342000},"page":"337-343","source":"Crossref","is-referenced-by-count":17,"title":["A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion"],"prefix":"10.1054","volume":"57","author":[{"given":"J.H.","family":"Check","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Angotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/mehy.2001.1333_RF1","first-page":"769","article-title":"Immunity to methylcholanthrene-induced sarcomas","volume":"18","author":"Prehn","year":"1957","journal-title":"J Natl Cancer Inst"},{"key":"10.1054\/mehy.2001.1333_RF2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.1997.03550220178023","article-title":"Tumor immunology","volume":"278","author":"Shu","year":"1997","journal-title":"JAMA"},{"key":"10.1054\/mehy.2001.1333_RF3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910070305","article-title":"Protection against spontaneous mouse mammary adenocarcinoma by inoculation of heat treated syngeneic mammary tumor cells","volume":"7","author":"Check","year":"1971","journal-title":"Int J Cancer"},{"key":"10.1054\/mehy.2001.1333_RF4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000395858","article-title":"Differences in the protective effect of complete Freund\u2019s adjuvant in spontaneous versus transplanted lymphomas in AKR mice","volume":"19","author":"Check","year":"1974","journal-title":"Immunol of Cancer. Prog Exp Tumor Res"},{"key":"10.1054\/mehy.2001.1333_RF5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bjc.1976.37","article-title":"A critique of the evidence for active host defense against cancer, based on personal studies of 27 murine tumors of spontaneous origin","volume":"33","author":"Hewitt","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1054\/mehy.2001.1333_RF6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00000658-198910000-00008","article-title":"Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients","volume":"210","author":"Rosenberg","year":"1989","journal-title":"Ann Surg"},{"key":"10.1054\/mehy.2001.1333_RF7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF02303818","article-title":"Cytokine-mediated gene therapy for cancer","volume":"1","author":"Miller","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"10.1054\/mehy.2001.1333_RF8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/07357909509011690","article-title":"Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment","volume":"13","author":"Vieweg","year":"1995","journal-title":"Cancer Invest"},{"key":"10.1054\/mehy.2001.1333_RF9","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/mehy.2001.1333_RF10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.177.4.1127","article-title":"Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells","volume":"177","author":"Connor","year":"1993","journal-title":"J Exp Med"},{"key":"10.1054\/mehy.2001.1333_RF11","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4049\/jimmunol.150.4.1458","article-title":"Antimetastatic vaccination of tumor-bearing mice with two types of IFN-y gene-inserted tumor cells","volume":"150","author":"Porgador","year":"1993","journal-title":"J Immunol"},{"key":"10.1054\/mehy.2001.1333_RF12","first-page":"2376","article-title":"Radioimmunoimaging in malignant melanoma with 111 In-labeled monoclonal antibody 96.5","volume":"45","author":"Murray","year":"1985","journal-title":"Cancer Res"},{"key":"10.1054\/mehy.2001.1333_RF13","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1996.14.7.1974","article-title":"Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma","volume":"14","author":"Kaminiski","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1054\/mehy.2001.1333_RF14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","article-title":"Selective in vitro growth of T lymphocytes from normal human bone marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"key":"10.1054\/mehy.2001.1333_RF15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1084\/jem.158.4.1356","article-title":"Lymphokine-activated killer cell phenomenon, III: evidence that IL-2 is sufficient for direct activation of peripheral blood into lymphokine-activated killer cells","volume":"158","author":"Grimm","year":"1983","journal-title":"J Exp Med"},{"key":"10.1054\/mehy.2001.1333_RF16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.iy.04.040186.003341","article-title":"Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes","volume":"4","author":"Rosenberg","year":"1986","journal-title":"Annu Rev Immunol"},{"key":"10.1054\/mehy.2001.1333_RF17","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"10.1054\/mehy.2001.1333_RF18","first-page":"1067","article-title":"In vivo activity of tumor infiltrating lymphocytes expanded in recombinant interleukin-2","volume":"79","author":"Spiess","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"10.1054\/mehy.2001.1333_RF19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/86.15.1159","article-title":"Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2","volume":"86","author":"Rosenberg","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1054\/mehy.2001.1333_RF20","first-page":"1043","article-title":"Clinical observations on adoptive immunotherapy with vaccine-primed T lymphocytes secondarily sensitized to tumor in vitro","volume":"53","author":"Chang","year":"1993","journal-title":"Cancer Res"},{"key":"10.1054\/mehy.2001.1333_RF21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4049\/jimmunol.147.2.729","article-title":"Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2","volume":"147","author":"Yashizawa","year":"1991","journal-title":"J Immunol"},{"key":"10.1054\/mehy.2001.1333_RF22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1997.15.2.796","article-title":"Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and IL-2","volume":"15","author":"Chang","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1054\/mehy.2001.1333_RF23","first-page":"215","article-title":"Controversies in reproductive immunology","volume":"11","author":"Clark","year":"1991","journal-title":"Crit Rev Immunol"},{"key":"10.1054\/mehy.2001.1333_RF24","series-title":"Immunology and Allergy Clinics of North America,","article-title":"Immunology of normal pregnancy","author":"Beer","year":"1998"},{"key":"10.1054\/mehy.2001.1333_RF25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/oxfordjournals.humrep.a019439","article-title":"Immunohistochemical evidence for increased numbers of \u2018classic\u2019 CD57+ natural killer cells in the endometrium of women suffering spontaneous early pregnancy loss","volume":"11","author":"Vassiliadou","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1054\/mehy.2001.1333_RF26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0378(96)00949-7","article-title":"Human decidual leukocytes do not proliferate in response to either extravillous trophoblast or allogeneic peripheral blood lymphocytes","volume":"30","author":"King","year":"1996","journal-title":"J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0897.1995.tb00884.x","article-title":"Isolation of decidual lymphocytes from chorionic villus samples: Phenotypic analysis and growth in vitro","volume":"33","author":"Haynes","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF28","first-page":"41","article-title":"Human uterine natural killer cells","volume":"15","author":"King","year":"1996","journal-title":"Nat Immun"},{"key":"10.1054\/mehy.2001.1333_RF29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0897.1996.tb00041.x","article-title":"Functions of human decidual NK cells","volume":"35","author":"King","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF30","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/oxfordjournals.humrep.a138436","article-title":"CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-beta 2-related immunosuppressive factors","volume":"9","author":"Clark","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1054\/mehy.2001.1333_RF31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0897.1999.tb00464.x","article-title":"The role of gamma\/delta T cells in progesterone-mediated immunomodulation during pregnancy: a review","volume":"42","author":"Szekeres-Bartho","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1600-0897.1996.tb00056.x","article-title":"Enhancement of the expression of progesterone receptor on progesterone treated lymphocyte after immunotherapy in unexplained recurrent spontaneous abortion","volume":"35","author":"Chiu","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0897.1985.tb00334.x","article-title":"The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis","volume":"9","author":"Szekeres-Bartho","year":"1985","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"10.1054\/mehy.2001.1333_RF34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0897.1995.tb00900.x","article-title":"Comparative analysis of the immunophenotypes of decidual and peripheral blood large granular lymphocytes and T cells during early human pregnancy","volume":"33","author":"Geiselhart","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0897.1996.tb00045.x","article-title":"Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation","volume":"35","author":"Check","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0897.1999.tb00433.x","article-title":"The role of gamma\/delta T cell receptor positive cells in pregnancy","volume":"41","author":"Polgar","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0897.1995.tb00962.x","article-title":"The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes","volume":"34","author":"Szekeres-Bartho","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0378(93)90063-N","article-title":"MHC class II compatibility in aborted fetuses and term infants of couples with recurrent spontaneous abortion","volume":"25","author":"Ober","year":"1993","journal-title":"J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF39","first-page":"Pecs, Hungary","article-title":"Recognition of HLA-G and HLA-E antigens by gamma-delta T cells during pregnancy [abstract]","author":"Barakonyi","year":"2000","journal-title":"6th Congress of the Alps-Adria Society of Immunology of Reproduction, June 27\u201330,"},{"key":"10.1054\/mehy.2001.1333_RF40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000292421","article-title":"A Randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus prrogesterone alone in habitual aborters","volume":"39","author":"Check","year":"1995","journal-title":"Gynecol Obstet Invest"},{"key":"10.1054\/mehy.2001.1333_RF41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0897.1997.tb00188.x","article-title":"Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)","volume":"37","author":"Check","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0897.1996.tb00493.x","article-title":"Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials","volume":"35","author":"Coulam","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0897.1999.tb00102.x","article-title":"Natural killer cell activity and cytokine production after in vitro immunoglobulin treatment of lymphocytes derived from pregnant women with or without risk for spontaneous abortion","volume":"42","author":"Szereday","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0897.1989.tb00999.x","article-title":"Alteration of lymphocyte reactivity in pregnant women treated with the progesterone receptor inhibitor ZK 98734","volume":"21","author":"Szekeres-Bartho","year":"1989","journal-title":"Am J Reprod Immunol"},{"key":"10.1054\/mehy.2001.1333_RF45","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/0002-9378(90)90713-H","article-title":"A progesterone-induced blocking factor corrects high resorption rates in mice treated with antiprogesterone","volume":"163","author":"Szekeres-Bartho","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/mehy.2001.1333_RF46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/cimm.1997.1090","article-title":"The antiabortive effective of progesterone-induced blocking factor in mice is manifested by modulating NK activity","volume":"177","author":"Szekeres-Bartho","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1054\/mehy.2001.1333_RF47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00006254-197802000-00001","article-title":"Indispensability of the human corpus luteum in the maintenance of early pregnancy: lutectomy evidence","volume":"3","author":"Csapo","year":"1978","journal-title":"Obstet Gynecol Surv"},{"key":"10.1054\/mehy.2001.1333_RF48","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/oxfordjournals.humrep.a136983","article-title":"Oocyte donation by gamete intrafallopian tranfer to amenorrheic and cycling patients given replacement steroids","volume":"4","author":"Formigli","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1054\/mehy.2001.1333_RF49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/1523-1747.ep12260181","article-title":"HLA-DR antigen expression in primary melanomas of the skin","volume":"82","author":"Brocker","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1054\/mehy.2001.1333_RF50","first-page":"102","article-title":"Immunoperoxidase staining for la-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma","volume":"115","author":"Wilson","year":"1984","journal-title":"Am J Pathol"},{"key":"10.1054\/mehy.2001.1333_RF51","first-page":"275","article-title":"Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast","volume":"152","author":"Zuk","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1054\/mehy.2001.1333_RF52","first-page":"923","article-title":"Expression and function class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ and DP antigens","volume":"5","author":"Sakai","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1054\/mehy.2001.1333_RF53","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/1097-0142(19900915)66:6<1154::AID-CNCR2820660613>3.0.CO;2-3","article-title":"An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma","volume":"66","author":"Hilton","year":"1990","journal-title":"Cancer"},{"key":"10.1054\/mehy.2001.1333_RF54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.2910380402","article-title":"Expression of HLA-D sub-region products on human colorectal carcinoma","volume":"38","author":"Ghosh","year":"1986","journal-title":"Int J Cancer"},{"key":"10.1054\/mehy.2001.1333_RF55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/bjc.1983.227","article-title":"Is heterogeneous expression of HLA-DR antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas?","volume":"48","author":"Rognum","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1054\/mehy.2001.1333_RF56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/bjc.1993.290","article-title":"Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis","volume":"68","author":"Andersen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1054\/mehy.2001.1333_RF57","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/1097-0142(19951015)76:8<1467::AID-CNCR2820760826>3.0.CO;2-A","article-title":"Human chorionic gonadotropin \u2013 beta subunit gene expression in cultured human fetal and cancer cells of different types and origins","volume":"76","author":"Acevedo","year":"1995","journal-title":"Cancer"},{"key":"10.1054\/mehy.2001.1333_RF58","first-page":"37","article-title":"Expression of hCG, its subunits and fragments by human cultured cancer cells of the nervous system","volume":"19","author":"Acevedo","year":"1995","journal-title":"Cancer Detect Prevent"},{"key":"10.1054\/mehy.2001.1333_RF59","first-page":"27","article-title":"In vivo expression of membrane-associated human chorionic gonadotropin by cells isolated from cancerous human tissues","volume":"34","author":"Acevedo","year":"1994","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1054\/mehy.2001.1333_RF60","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin\u2019s lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1054\/mehy.2001.1333_RF61","doi-asserted-by":"crossref","first-page":"916","DOI":"10.7326\/0003-4819-132-11-200006060-00012","article-title":"Emerging immunotherapies for non-Hodgkin lymphomas: The tortoise approaches the finish line","volume":"132","author":"Press","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1054\/mehy.2001.1333_RF62","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1996.14.7.1974","article-title":"Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma","volume":"14","author":"Kaminski","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1054\/mehy.2001.1333_RF63","first-page":"457","article-title":"Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma","volume":"2","author":"Knox","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1054\/mehy.2001.1333_RF64","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1200\/JCO.1999.17.12.3793","article-title":"Phase I\/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20-positive B-cell non-Hodgkin\u2019s lymphoma","volume":"17","author":"Witzig","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1054\/mehy.2001.1333_RF65","first-page":"2a","article-title":"I-131 anti-B1 antibody for previously untreated follicular lymphoma: clinical and molecular remissions [abstract]","volume":"17","author":"Kaminski","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1054\/mehy.2001.1333_RF66","first-page":"Pecs, Hungary","article-title":"Effect of recombinant PIBF on gamma-delta TCR expression [abstract]","author":"Laki","year":"2000","journal-title":"6th Congress of the Alps-Adria Society of Immunology of Reproduction, June 27\u201330,"},{"key":"10.1054\/mehy.2001.1333_RF67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01541085","article-title":"Immunobiology and pharmacology of organ allograft rejection","volume":"15","author":"Sutherland","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1054\/mehy.2001.1333_RF68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0167-5699(93)90235-D","article-title":"Bi-directional cytokine interaction in maternal-fetal relationship: is successful pregnancy a TH 1 phenomenon?","volume":"11","author":"Wegmann","year":"1993","journal-title":"Immunol Today"},{"key":"10.1054\/mehy.2001.1333_RF69","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.4049\/jimmunol.151.9.4562","article-title":"Synthesis of T helper 2 type cytokines at the maternal fetal interface","volume":"151","author":"Lin","year":"1993","journal-title":"J Immunol"},{"key":"10.1054\/mehy.2001.1333_RF70","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/jama.1995.03520480053039","article-title":"T helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion","volume":"273","author":"Hill","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1054\/mehy.2001.1333_RF71","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0015-0282(00)00517-3","article-title":"Evidence of a TH 1 type response associated with recurrent miscarriage","volume":"73","author":"Jenkins","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1054\/mehy.2001.1333_RF72","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/2006","article-title":"Defective production of both LIF and type 2 T helper cytokines by decidual T cells in unexplained recurrent abortion","volume":"4","author":"Picinni","year":"1998","journal-title":"Nat Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987701913337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987701913337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:37:25Z","timestamp":1682141845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987701913337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0306987701913337"],"URL":"https:\/\/doi.org\/10.1054\/mehy.2001.1333","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}